Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program

Area of Science:

• Pulmonary Medicine
• Hematology
• Cardiorespiratory Physiology

Background:

• Thalassemia is a genetic blood disorder requiring chronic blood transfusions.
• Hypertransfusion programs aim to manage severe thalassemia but may have systemic effects.
• Lung function in thalassemia patients on chronic transfusion therapy is not fully understood.

Purpose of the Study:

• To assess pulmonary function abnormalities in thalassemia patients on a hypertransfusion program.
• To identify specific patterns of lung dysfunction in this patient cohort.
• To explore potential correlations between pulmonary function and disease/treatment factors.

Main Methods:

• Conducted comprehensive pulmonary function tests (PFTs) on 12 thalassemia patients.
• Included spirometry, lung volumes (body plethysmography), gas exchange (single-breath nitrogen washout, diffusing capacity), and arterial blood gases.
• Evaluated parameters for abnormalities indicative of airway obstruction, hyperinflation, and gas exchange impairment.

Main Results:

• Only one of 12 patients had normal pulmonary function.
• Ten patients presented with resting arterial hypoxemia.
• Abnormalities included increased residual volume (5/12), abnormal slope of phase III nitrogen washout (5/12), and decreased maximal expiratory flow rates suggesting small airway disease (4/12).
• Total lung capacity and single-breath carbon monoxide diffusing capacity were generally normal.
• Pulmonary function abnormalities did not correlate with age or iron levels from transfusions.

Conclusions:

• Thalassemia patients on hypertransfusion therapy frequently exhibit significant pulmonary dysfunction.
• Small airway obstruction, hyperinflation, and hypoxemia are key findings.
• These abnormalities may stem from the underlying thalassemia, iron overload in the lungs, or other contributing factors.